CVE-2022-47376
Summary
| CVE | CVE-2022-47376 |
|---|---|
| State | PUBLIC |
| Assigner | [email protected] |
| Source Priority | CVE Program / NVD first with legacy fallback |
| Published | 2023-06-13 20:15:00 UTC |
| Updated | 2023-06-24 01:14:00 UTC |
| Description | The Alaris Infusion Central software, versions 1.1 to 1.3.2, may contain a recoverable password after the installation. No patient health data is stored in the database, although some site installations may choose to store personal data. |
Risk And Classification
Problem Types: CWE-522
NVD Known Affected Configurations (CPE 2.3)
| Type | Vendor | Product | Version | Update | Edition | Language |
|---|---|---|---|---|---|---|
| Application | Bd | Alaris Infusion Central | All | All | All | All |
References
| Reference | Source | Link | Tags |
|---|---|---|---|
| Alaris™ Infusion Central – Recoverable Password Vulnerability | MISC | www.bd.com | |
| CVE Program record | CVE.ORG | www.cve.org | canonical |
| NVD vulnerability detail | NVD | nvd.nist.gov | canonical, analysis |
No vendor comments have been submitted for this CVE.
There are currently no legacy QID mappings associated with this CVE.